NovoCure Limited NVCR

Full chart Compare
Set alert

Price alert · NVCR

All alert types
14.61 USD +1.18 (+8.79%)

At closeNov 4, 2026, 4:00 PM EST

14.61 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

13.92 Day range 14.94
9.82 52-week range 21.45
YTD
+12.99%
1 year
+21.75%

Financial health

Altman Z-Score

0.78 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -10.6×
FY 2016: -5.1×FY 2017: -28.9×FY 2018: -48.5×FY 2019: -1133×FY 2020: 865×FY 2021: -134×FY 2022: -83.4×FY 2023: -7.7×FY 2024: -19.1×FY 2025: -10.6×
FY 2016 5y median -19.1× FY 2025
P/S 2.2×
FY 2016: 8.1×FY 2017: 10.1×FY 2018: 12.4×FY 2019: 23.3×FY 2020: 35.3×FY 2021: 14.5×FY 2022: 14.3×FY 2023: 3.1×FY 2024: 5.3×FY 2025: 2.2×
FY 2016 5y median 5.3× FY 2025
P/B 4.2×
FY 2016: 4.7×FY 2017: 15.8×FY 2018: 27.4×FY 2019: 37.6×FY 2020: 36.7×FY 2021: 18.9×FY 2022: 17.4×FY 2023: 4.4×FY 2024: 8.9×FY 2025: 4.2×
FY 2016 5y median 8.9× FY 2025
P/FCF -19.0×
FY 2016: -5.4×FY 2017: -44.2×FY 2018: -358×FY 2019: 508×FY 2020: 207×FY 2021: 133×FY 2022: 814×FY 2023: -15.8×FY 2024: -46.4×FY 2025: -19.0×
FY 2016 5y median -15.8× FY 2025
EV/EBITDA -13.4×
FY 2016: -6.1×FY 2017: -62.1×FY 2018: -132×FY 2019: 606×FY 2020: 394×FY 2021: -212×FY 2022: -120×FY 2023: -11.0×FY 2024: -34.1×FY 2025: -13.4×
FY 2016 5y median -34.1× FY 2025
EV/Sales 2.5×
FY 2016: 8.1×FY 2017: 10.2×FY 2018: 12.4×FY 2019: 23.3×FY 2020: 35.7×FY 2021: 15.2×FY 2022: 15.1×FY 2023: 3.8×FY 2024: 6.2×FY 2025: 2.5×
FY 2016 5y median 6.2× FY 2025
FCF Yield -5.3%
FY 2016: -18.6%FY 2017: -2.3%FY 2018: -0.3%FY 2019: 0.2%FY 2020: 0.5%FY 2021: 0.8%FY 2022: 0.1%FY 2023: -6.3%FY 2024: -2.2%FY 2025: -5.3%
FY 2016 5y median -2.2% FY 2025

Profitability

Gross Margin 74.5%
FY 2016: 44.2%FY 2017: 68.6%FY 2018: 67.7%FY 2019: 74.8%FY 2020: 78.5%FY 2021: 78.5%FY 2022: 78.6%FY 2023: 74.8%FY 2024: 77.3%FY 2025: 74.5%
FY 2016 5y median 77.3% FY 2025
Operating Margin -23.5%
FY 2016: -139.1%FY 2017: -22.2%FY 2018: -13.6%FY 2019: -0.3%FY 2020: 6.1%FY 2021: -8.3%FY 2022: -16.6%FY 2023: -45.7%FY 2024: -28.2%FY 2025: -23.5%
FY 2016 5y median -23.5% FY 2025
Net Margin -20.8%
FY 2016: -159.1%FY 2017: -34.8%FY 2018: -25.6%FY 2019: -2.1%FY 2020: 4.0%FY 2021: -10.9%FY 2022: -17.2%FY 2023: -40.6%FY 2024: -27.9%FY 2025: -20.8%
FY 2016 5y median -20.8% FY 2025
ROE -40.0%
FY 2016: -92.6%FY 2017: -54.3%FY 2018: -56.6%FY 2019: -3.3%FY 2020: 4.2%FY 2021: -14.2%FY 2022: -21.0%FY 2023: -57.1%FY 2024: -46.8%FY 2025: -40.0%
FY 2016 5y median -40.0% FY 2025
ROIC -25.9%
FY 2016: -47.0%FY 2017: -18.3%FY 2018: -12.2%FY 2019: -0.2%FY 2020: 3.2%FY 2021: -4.4%FY 2022: -8.7%FY 2023: -24.1%FY 2024: -16.2%FY 2025: -25.9%
FY 2016 5y median -16.2% FY 2025
ROA -16.9%
FY 2016: -46.7%FY 2017: -23.2%FY 2018: -18.7%FY 2019: -1.5%FY 2020: 1.9%FY 2021: -5.1%FY 2022: -7.8%FY 2023: -18.1%FY 2024: -13.6%FY 2025: -16.9%
FY 2016 5y median -13.6% FY 2025

Growth (YoY)

Revenue 8.3%
FY 2016: 150.5%FY 2017: 113.6%FY 2018: 40.1%FY 2019: 41.6%FY 2020: 40.7%FY 2021: 8.2%FY 2022: 0.5%FY 2023: -5.3%FY 2024: 18.8%FY 2025: 8.3%
FY 2016 FY 2025
Operating Income 9.8%
FY 2016: -10.9%FY 2017: 65.9%FY 2018: 14.4%FY 2019: 97.3%FY 2020: 3426.1%FY 2021: -245.8%FY 2022: -101.9%FY 2023: -160.1%FY 2024: 26.8%FY 2025: 9.8%
FY 2016 FY 2025
EPS (diluted) 21.8%
FY 2016: -14.9%FY 2017: 54.5%FY 2018: 1.4%FY 2019: 89.2%FY 2020: 341.9%FY 2021: -411.1%FY 2022: -57.1%FY 2023: -121.6%FY 2024: 20.0%FY 2025: 21.8%
FY 2016 FY 2025
Free Cash Flow -9.3%
FY 2016: -13.7%FY 2017: 67.7%FY 2018: 78.8%FY 2019: 288.1%FY 2020: 421.7%FY 2021: -30.4%FY 2022: -83.9%FY 2023: -1165.0%FY 2024: 31.1%FY 2025: -9.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.9×
FY 2016: 7.1×FY 2017: 4.9×FY 2018: 5.0×FY 2019: 5.1×FY 2020: 8.8×FY 2021: 7.5×FY 2022: 7.0×FY 2023: 5.8×FY 2024: 1.5×FY 2025: 2.9×
FY 2016 5y median 5.8× FY 2025
Quick Ratio 2.7×
FY 2016: 6.4×FY 2017: 4.4×FY 2018: 4.6×FY 2019: 4.8×FY 2020: 8.6×FY 2021: 7.4×FY 2022: 6.8×FY 2023: 5.6×FY 2024: 1.4×FY 2025: 2.7×
FY 2016 5y median 5.6× FY 2025
Debt / Equity 0.9×
FY 2016: 0.7×FY 2017: 0.9×FY 2018: 1.3×FY 2019: 0.8×FY 2020: 0.9×FY 2021: 1.4×FY 2022: 1.3×FY 2023: 1.6×FY 2024: 1.9×FY 2025: 0.9×
FY 2016 5y median 1.4× FY 2025
Net Debt / EBITDA -1.5×
FY 2016: 0.0×FY 2017: -0.6×FY 2018: -0.4×FY 2019: -0.8×FY 2020: 4.6×FY 2021: -9.7×FY 2022: -6.9×FY 2023: -2.0×FY 2024: -4.7×FY 2025: -1.5×
FY 2016 5y median -4.7× FY 2025
Interest Coverage 0.0×
FY 2016: -16.7×FY 2017: -3.4×FY 2018: -2.0×FY 2019: -0.1×FY 2020: 1.7×FY 2021: -5.0×FY 2022: -11.0×FY 2023: -47.5×FY 2024: -14.6×FY 2025: 0.0×
FY 2016 5y median -11.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31